- Disease
- Metastatic Pancreatic Adenocarcinoma
- Diffuse midline glioma (DMG) with H3K27M mutation.
- Gastrointestinal Stromal Tumors (GISTs)
- HER2-Negative Breast Cancer
- HER2-Positive breast cancer
- Non-small Cell Lung cancer(NSCLC)
- desmoid tumors in adults
- Desmoid-Type Fibromatosis
- Rare Diseases
- Soft Tissue Tumors
- High-risk myelofibrosis
- Cholangiocarcinoma with FGFR2 gene fusion
- Medullary thyroid cancer (MTC)
- Chronic Lymphocytic Leukemia,SLL,MCL
- Melanoma
- Metastatic melanoma with BRAF V600E mutation
- IDH1-Mutant Gliomas
- Other IDH1-Mutated Cancer
- Breast Cancer
- hormone receptor-positive (HR+)
- Renal Cell Carcinoma
- Soft Tissue Sarcoma (STS)
- Chronic Myelogenous Leukemia (CML)
- Ovarian cancer
- Multiple myeloma
- Hepatocellular Carcinoma (HCC)
- Other cancers
- Epithelioid Sarcoma
- Follicular Lymphoma
- Nonalcoholic steatohepatitis (NASH)
- BRAF V600E or V600K mutation-positive metastatic melanoma.
- HR-Positive
- Prostate cancer
- Solid Tumors
- Advanced Renal Cell Carcinoma (RCC)
- Metastatic colorectal cancer,GISTs
- Metastatic non-small cell lung cancer (NSCLC)
- Erdheim Chester Disease
- B-cell malignancies
- Broad-spectrum antitumor agents
- Colorectal cancer
- Broad-spectrum anti-cancer drug
- Metastatic urothelial carcinoma
- postmenopausal women men with breast cancer
- Type 1 neurofibromatosis
- Adrenal cortex carcinoma
- Treat RET gene fusion positive NSCLC and MTC
- Large B-cell lymphoma
- leukaemia
Related News
-
LuciDarax Side Effects, Clinical Trials & FAQs
Introduction Starting treatment for metastatic pancreatic cancer involves more than understanding how…
2026-10-08
-
LuciDarax (Daraxonrasib) Dosage and Administration: A Patient-Friendly Safety Guide
Introduction Starting an oral cancer treatment can feel overwhelming. Patients may have…
2026-10-08
-
LuciDarax (Daraxonrasib): Understanding Its Role in RAS-Driven Pancreatic Cancer
Introduction A diagnosis of metastatic pancreatic cancer can bring difficult treatment decisions…
2026-10-08
-
LuciDarax (Daraxonrasib) Clinical Trials, Distribution & Value in Precision Oncology
Clinical Trials of LuciDarax (Daraxonrasib) The clinical development of LuciDarax (Daraxonrasib) has…
2026-10-05
-
RASONQUE™(Daraxonrasib): Dosage Instructions, Side Effects, FAQ & Myths
How to Take RASONQUE™ (Daraxonrasib) Safely and Effectively Take it exactly as…
2026-10-03
-
Turning Off the Signal That Fuels Cancer: RASONQUE™ (Daraxonrasib) Overview
Turning Off the Signal That Fuels Cancer: RASONQUE™ (Daraxonrasib) Overview When Every…
2026-10-01
